ATIF signs new $800,000 Listing advisory agreement

Stock Information for Eagle Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eagle Pharmaceuticals Inc.

ATIF Holdings Limited Announces Approximately $2.5 Million Registered Direct and Private Placement
New Century, consulted by ATIF, successfully listed on Nasdaq
ATIF Announces Change of its Nasdaq Ticker Symbol to "ZBAI"
ATIF Announces Plan to Change its Nasdaq Ticker Symbol to "ZBAI"
ATIF Signs Two New Listing Advisory Agreements
ARMLOGI, consulted by ATIF, successfully listed on Nasdaq
Massimo Reported 2023 Financial Results
MASSIMO, consulted by ATIF, successfully listed on Nasdaq

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.